3/20/2024 0 Comments Autumn alk dean blair![]() Idowu OS, Craigen JL, Veal GJ, Jamieson D.Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report.Ĭancer Chemotherapy and Pharmacology 2023, 92, 325–328. Barnett S, Nyein AC, Galler M, Jamieson D, Davies M, Connor P, Veal GJ.Newcastle NHS Special Trustees, project grant. D Jamieson & HY Leung: Establishment of a high throughput screen for modifiers of apoptosis and cell cycle kinetics in a metastatic prostate cancer cell line for drug and drug target discovery.Nuffield Science Bursaries Undergraduate Research. AV Boddy, D Jamieson, KKN Chan: Relationship between genotype and reductase enzyme activity in bladder and ovarian tumours.D Jamieson, FEB May, AV Boddy: Application to JGWP for consumable money to investigate NQO2 in kinase mediated signalling in breast cancer – 2008 to 2009, £16, 561 awarded.D Jamieson, AV Boddy, R Plummer: Capital costs for purchase of ImageStreamX imaging flow cytometer.D Jamieson, AV Boddy, R Plummer, N Curtain, H Reeves, R Edmondson, C Robson, FEB May: Development of CTC assays.Prognostic, predictive and pharmacodynamic value of circulating tumour cells in oesophagogastric cancer patients in receipt of palliative systemic therapy. Welcome Trust Biomedical Vacation Scholarship. Feasibility of detection and enumeration of Circulating Tumour Cells in Thyroid Cancer using the Veridex LLC (Cell-Search) and the ImageStreamX Mark II (Amnis) flow cytometry methods – A Newcastle-Manchester joint pilot study. UK Mallick, V Paleri, GJ Veal, P Perros, TWJ Lennard, ER Plummer, D Jamieson.Pharmacogenetics of Doxorubicin, Gemcitabine and Docetaxel in Patients studied on the GeDDiS trial (Sarcoma). CTC pharmacodynamic assay for C/EBPa saRNA phase I trial. A pilot project to investigate the added utility of circulating miRNAs in distinguishing between response and toxicity in patients with primary brain tumours treated with chemoradiotherapy. AP Greystoke, D Jamieson, GJ Veal, SR Wedge.Understanding neuroblastoma heterogeneity: Genetic studies of circulating neuroblastoma tumour cells. AZD3965 - A monocarboxylate transporter 1 inhibitor in patients with advanced cancer. CTC, IHC and Nanostring pharmacodynamic assays for MIV-818 phase I trial. Liver Cancer – Developing DNA-PK as a predictive biomarker and clinical target. Reeves, D Palmer, S Wedge, D Jamieson R, Shukla. The Alice Stephenson Bequest PhD studentship. Identification of ‘liquid biopsy’ predictive biomarkers in patients with advanced hepatocellular carcinoma. €11,995,060.5 awarded (of which €1,380,141.25 allocated to Newcastle University & €218,216.25 allocated to The Newcastle upon Tyne Hospitals NHS Foundation Trust) Tumour-host interactions in liver cancer of childhood and adults. Llovet on behalf of the THRIVE consortium. Imaging flow cytometry and quantitative image analysis.Establishment of methods to detect circulating tumour cells. ![]() ![]() Investigation, development and validation of biomarkers for pharmacodynamic endpoints in early phase clinical trials.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |